No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Xencor Inc : Raymond James Adds Stock to Its Analyst Current Favorites List
All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy
Xencor Initiated at Overweight by Wells Fargo
Wells Fargo Initiates Xencor(XNCR.US) With Buy Rating, Announces Target Price $37
Promising Prospects for Xencor's Plamotamab in Autoimmune Treatments Drive Buy Rating
Piper Sandler Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $30